Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Meissa Vaccines

Meissa Vaccines

A pharmaceutical company focused on advancement of unmet vaccines against viruses that cause serious human diseases such as respiratory syncytial virus (RSV). Meissa Vaccines applies their platform technology for viral genetic engineering to multiple pathogens.

OverviewStructured DataIssuesContributorsActivity

All edits by  Nika Nika 

Edits on 9 May, 2022
Nika Nika profile picture
Nika Nika
edited on 9 May, 2022
Edits made to:
Infobox (+8 properties)
Table (+1 rows) (+3 cells) (+138 characters)
Table

Title
Author
Link
Type
Date

Bloomberg - Are you a robot?

https://www.bloomberg.com/news/features/2022-04-25/can-nasal-sprays-work-on-covid-meissa-vaccines-thinks-so

Web

Infobox
Competitors
Pfizer
Pfizer
Johnson & Johnson
Johnson & Johnson
AstraZeneca
AstraZeneca
Moderna Therapeutics
Moderna Therapeutics
Novavax
Novavax
BioNTech
BioNTech
The Gamaleya National Center.
The Gamaleya National Center.
Products

Find more companies like Meissa Vaccines

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.